Pearl Ugwu‐Dike - Concepedia

Author

Pearl Ugwu‐Dike

Massachusetts General Hospital ORCID

Also Known As

P. Ugwu-Dike, P. Ugwu‐Dike, Pearl O. Ugwu-Dike, Pearl Ojiugo Ugwu-Dike, Pearl Ugwu-Dike, Pearl Ugwu‐Dike

Publications

375

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Johns Hopkins University Harvard University Washington University in St. Louis Johns Hopkins Medicine

About

Pearl Ugwu‐Dike is an author at Massachusetts General Hospital specializing in dermatology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	102
2	Immunology	2	2	83
3	Public Health	1	1	10
4	Allergy	1	1	19
5	Epidemiology	1	1	10

Pearl Ugwu‐Dike

Publications

337

Citations

H-Index

Page 1

	Year	Citations
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Therapy Kimberly Tang, Jayhyun Seo, Bruce C. Tiu, JAMA Dermatology	2022	121
Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study Bruce C. Tiu, Leyre Zubiri, James Iheke, Journal for ImmunoTherapy of Cancer	2022	82
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study Shijia Zhang, Kimberly Tang, Guihong Wan, Journal of the American Academy of Dermatology Cancer ImmunosurveillanceMedicineImmune Checkpoint InhibitorsAdvanced Cancer PatientsImmunology	2023	68
The utility of robotic assisted pancreas transplants – a single center retrospective study Mario Spaggiari, Kiara Tulla, Obi Okoye, Transplant International	2019	22
Biologics utilization for psoriasis is lower in black compared with white patients Wesley T. Hodges, Trisha Bhat, Neel S. Raval, British Journal of Dermatology AllergyMedicineBiologics UtilizationClinical DermatologyWhite Patients	2021	19
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy Nga Nguyen, Guihong Wan, Pearl Ugwu‐Dike, Journal of the American Academy of Dermatology Melanoma TypeAutoimmune DiseaseMedicineMelanomaImmunology	2023	15
Racial and socioeconomic differences in acral lentiginous melanoma outcomes: A Surveillance, Epidemiology, and End Results analysis Neel S. Raval, Wesley T. Hodges, Pearl Ugwu‐Dike, Journal of the American Academy of Dermatology Skin CancerMelanomaBlack WomenSocioeconomic DifferencesSocial Determinants Of Health	2021	10

Page 1